glp 1 ra drugs list GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits Chart: 1 in 8 Americans

Usage Cited in: J Cell Biochem

See /coa for the published wall

May Reduce the Chance of Re-Injury One overlooked benefit of peptides for injury recovery is their potential to lower the risk of future injuries

This represents the best-quality clinical evidence for DSIP, though the sample size was small Multi-species animal data -- DSIP has demonstrated sleep-promoting effects in rabbits, mice, rats, cats, and humans Stress modulation -- DSIP suppresses stress-induced cortisol and ACTH rises, potentially relevant for stress-related insomnia Opioid and alcohol withdrawal -- small studies explored DSIP as an adjunct in withdrawal management 2024 fusion peptide study -- published in Frontiers in Pharmacology, research on DSIP-BBB fusion peptides in insomnia mouse models represents renewed interest in DSIP Important limitations of DSIP's clinical evidence: Most studies are from the 1980s-1990s, conducted before modern polysomnography and sleep study methodology were standardized Sample sizes are consistently small Results are inconsistent across studies -- some show clear sleep effects while others do not No large-scale, placebo-controlled RCTs have been conducted Publication bias (positive results more likely published) may inflate the apparent evidence Side Effects Comparison# Cortistatin Side Effects# No human safety data exists

Patients in active cancer treatment should never start glutathione supplementation, oral or IV, without clearance from their oncologist